美国法官驳回联邦贸易委员会阻止私募股权医疗公司交易的请求

路透中文
Nov 11, 2025
美国法官驳回联邦贸易委员会阻止私募股权医疗公司交易的请求

路透11月10日 - 芝加哥一名联邦法官周一裁定,私募股权公司GTCR可以继续推进对医疗器械涂层制造商SurmodicsSRDX.O的收购,驳回了美国联邦贸易委员会阻止这一交易的要求。

联邦贸易委员会于今年3月起诉阻止该交易,这是该委员会在特朗普总统第二任期内首次起诉阻止并购。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10